rivastigmine / Generic mfg.  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
rivastigmine / Generic mfg.
RIVA-PSP, NCT02839642: Efficacy of RIVAstigmine on Motor, Cognitive and Behavioural Impairment in Progressive Supranuclear Palsy

Completed
3
106
Europe
Rivastigmine, Placebo
Assistance Publique Hopitaux De Marseille
Progressive Supranuclear Palsy (PSP)
06/22
11/22
NCT05564169: Masitinib in Patients With Mild to Moderate Alzheimer's Disease

Not yet recruiting
3
600
Europe
Placebo, Placebo Oral Tablet, Masitinib (4.5), AB1010, Standard of care
AB Science
Alzheimer Disease
12/26
12/26

Download Options